Page 83 - Bio News Today

The body of an Owensboro barber, Johnny Goodman, Jr., who was last seen December 13th has been found. Our medi...

'Tis the season for Christmas music to be playing on all radio stations across the nation. While some stations...

Daviess County Public Schools swore in Tuesday the new DCPS Police Department Sub Officer. Jason Goddard comes...

Biotest Aktiengesellschaft (ETR:BIO – Get Free Report) shares traded up 1% on Monday . The company traded as high as €42.40 ($45.59) and last traded at €42.40 ($45.59). 100 shares were traded during mid-day trading, a decline of 95% from the average session volume of 1,927 shares. The stock had previously closed at €42.00 ($45.16). […]

Biotest Aktiengesellschaft (ETR:BIO – Get Free Report)’s stock price rose 1% during mid-day trading on Monday . The stock traded as high as €42.40 ($45.59) and last traded at €42.40 ($45.59). Approximately 100 shares traded hands during mid-day trading, a decline of 95% from the average daily volume of 1,927 shares. The stock had previously […]

UBS Group started coverage on shares of Bio-Rad Laboratories (NYSE:BIO – Free Report) in a research report sent to investors on Thursday morning, MarketBeat reports. The brokerage issued a buy rating and a $395.00 price objective on the medical research company’s stock. Separately, StockNews.com cut shares of Bio-Rad Laboratories from a buy rating to a […]

UBS Group assumed coverage on shares of Bio-Rad Laboratories (NYSE:BIO – Free Report) in a report released on Thursday, Marketbeat reports. The brokerage issued a buy rating and a $395.00 price objective on the medical research company’s stock. Separately, StockNews.com cut Bio-Rad Laboratories from a buy rating to a hold rating in a report on […]

UBS Group started coverage on shares of Bio-Rad Laboratories (NYSE:BIO – Free Report) in a research note published on Thursday, MarketBeat.com reports. The brokerage issued a buy rating and a $395.00 price target on the medical research company’s stock. Separately, StockNews.com lowered shares of Bio-Rad Laboratories from a buy rating to a hold rating in […]

Analysts at UBS Group assumed coverage on shares of Bio-Rad Laboratories (NYSE:BIO – Get Free Report) in a note issued to investors on Thursday, Briefing.com reports. The firm set a “buy” rating and a $395.00 price target on the medical research company’s stock. UBS Group’s price target would suggest a potential upside of 27.12% from […]

Shin Yoo-yeol, the heir apparent of Lotte Groups owner family, will be in charge of finding the firm’s next growth engines and mapping out its medium- to long-term vision, the company said Wednesday during a year-end reshuffle of top management.